08:18 AM EDT, 06/28/2024 (MT Newswires) -- Health care stocks were trending lower pre-bell Friday, with the Health Care Select Sector SPDR Fund (XLV) down 4.9% and the iShares Biotechnology ETF (IBB) unchanged.

Carisma Therapeutics ( CARM ) said late Thursday that it nominated an in vivo CAR-M targeting Glypican-3 as the first development candidate under its collaboration with Moderna ( MRNA ) . Carisma shares rose more than 36% and Moderna ( MRNA ) shares were up 1.6% pre-bell Friday.